Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | BRD2 | P25440 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NEK2 | P51955 | 1/20 | 0.31 |
| ▸ | INMT | O95050 | 2/20 | 0.30 |
| ▸ | GSK3A | P49840 | 2/20 | 0.30 |
| ▸ | GSK3B | P49841 | 2/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14428797 | 0.86 | BRD4 (0.52) | BRD4BRD2CRBNKMT2AMEN1 | |
| SCHEMBL9602154 | 0.79 | MEN1 (0.32) | BRD4BRD2KMT2AMEN1 | |
| SCHEMBL12724765 | 0.79 | BRD4 (0.31) | BRD4BRD2 | |
| SCHEMBL12208453 | 0.79 | GAA (0.42) | BRD4BRD2PIK3CDINMT | |
| SCHEMBL12890580 | 0.79 | PIK3CD (0.35) | BRD4BRD2PIK3CD | |
| SCHEMBL27666999 | 0.79 | BRD4 (0.31) | BRD4BRD2 | |
| SCHEMBL9602149 | 0.79 | BRD4 (0.31) | BRD4BRD2 | |
| SCHEMBL2398125 | 0.77 | BRD4 (0.43) | BRD4BRD2CRBNPIK3CDKMT2A | |
| SCHEMBL228923 | 0.77 | — | — | |
| SCHEMBL3043 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111892696-A | Dithienobenzene fused ring quinoxaline conjugated polymer and preparation method and application thereof | 华南理工大学 | 2020-11-06 | — | — | CN | claimed |
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, LLC | 2008-03-06 | — | — | US | claimed |
| WO-2004078874-A2 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | POLAROID CORPORATION (US) | 2004-09-16 | — | — | WO | claimed |
| US-20040171817-A1 | Novel dye complexes and use thereof in imaging members and methods | ZINK HOLDINGS LLC | 2004-09-02 | — | — | US | claimed |
| US-12584083-B2 | Surface treatment composition, surface treatment method, and method for producing semiconductor substrate | FUJIMI INCORPORATED (JP) | 2026-03-24 | — | — | US | disclosed |
| CN-114875094-B | Method for improving fermentation yield of thaxtomin | 中国科学院微生物研究所 | 2024-07-02 | — | — | CN | disclosed |
| US-20240124810-A1 | SURFACE TREATMENT COMPOSITION, SURFACE TREATMENT METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE | FUJIMI INCORPORATED (JP) | 2024-04-18 | — | — | US | disclosed |
| CN-117778117-A | Surface treatment composition, surface treatment method, and method for manufacturing semiconductor substrate | 福吉米株式会社 | 2024-03-29 | — | — | CN | disclosed |
| US-20240083926-A1 | PHOSPHORUS COMPOUNDS AND METHODS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2024-03-14 | — | — | US | disclosed |
| EP-3983402-B1 | 1-((S)-1-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)ETHYL)-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES | PHARVARIS GMBH (CH) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023140146-A1 | POLISHING COMPOSITION, CONCENTRATED SOLUTION OF POLISHING COMPOSITION, AND POLISHING METHOD | 株式会社フジミインコーポレーテッド | 2023-07-27 | — | — | WO | disclosed |
| EP-2435497-B1 | POLYCYCLIC DITHIOPHENES | CLAP CO LTD (KR) | 2023-07-05 | — | — | EP | disclosed |
| EP-1597084-A2 | IMAGING SYSTEM | Polaroid Corporation (US) | 2005-11-23 | — | — | EP | disclosed |
| WO-2004078874-A2 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | POLAROID CORPORATION (US) | 2004-09-16 | — | — | WO | disclosed |
| WO-2004078479-A2 | IMAGING SYSTEM | POLAROID CORPORATION (US) | 2004-09-16 | — | — | WO | disclosed |
| US-20040176248-A1 | Imaging system | ZINK HOLDINGS LLC | 2004-09-09 | — | — | US | disclosed |
| US-20040171817-A1 | Novel dye complexes and use thereof in imaging members and methods | ZINK HOLDINGS LLC | 2004-09-02 | — | — | US | disclosed |
| US-6121442-A | 1,2-dialkinylated compounds | UNIVERSITY OF HEILDELBERG (DE) | 2000-09-19 | — | — | US | disclosed |
| US-4892556-A | Process for transfer printing on leather substrates impregnated with aminoplast pre-condensate | SCHULZEN HERBERT W A (DE) | 1990-01-09 | — | — | US | disclosed |
| EP-0226818-A2 | Process for printing on leather substrates | Nortech Chemie GmbH & Co. KG (DE) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083926-A1 | PHOSPHORUS COMPOUNDS AND METHODS THEREOF | PHPT1, PTH1R, SOST | BRD4 4833/4885BRD2 4695/4885CRBN 2827/4885 |
| US-12584083-B2 | Surface treatment composition, surface treatment method, and method for producing semiconductor substrate | PIEZO1, TYRO3, ACP1 | BRD4 3712/4885BRD2 3142/4885CRBN 771/4885 |
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | DBI, HSPE1, ABCB7 | BRD4 109/4885BRD2 801/4885CRBN 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.